Ipsen invests in the wider global community focusing our efforts on patient associations and charitable work. Our commitment reflects our corporate social responsibility policy and we believe that our employees are our leading ambassadors.
Promoting the needs and rights of patients, employees and society at large is really important, and it is exactly the objective and essence of our Corporate Social Responsibility strategy: A human journey of shared commitments. Our vision is to harness the power of our employees to have a responsible and sustainable impact on patients, society and the environment.
Dominique Laymand, Executive Vice-President, Chief Ethics and Compliance Officer
Examples of our Corporate Citizenship include:
In China, the TUEAF (Tianjin United Education Assistance Foundation) is a non-governmental organization established in July 2005 to raise funds to help educate disadvantaged students from single-mother families on orphans. Donations to this NGO in 2014 provided funding to support training of more than 500 teachers from ten schools across China.
Ipsen China has also sponsored a disease information campaign held by the China Health Promotion Foundation’s (CHPF) Inflammatory Bowel Disease (IBD) Fund in 19 cities. The project’s objectives were to provide patients with accurate information on IBD and its treatment, and ultimately improve disease management and long-term care.
Ipsen introduced a personalized training support program for patients (APPRI) using our recombinant growth hormone NutropinAq® and the NutropinAq® injection. The program increased their autonomy at home during treatment, as well as their compliance with the treatment regimen.
Ipsen personnel in France have also joined forces to help patients suffering from disabling diseases associated with neuroendocrine tumors. As well as their participation in the “Course des Héros”, they raised funds to support the patient group APTED.
Since 2009, Ipsen has been engaged in a proactive approach to enable individuals with disabilities to find employment in the company. In France, Ipsen, concluded a partnership with HandiEM, an organization founded by the Leem (French pharmaceutical trade association) to implement a pharmaceutical industry-wide agreement for the disabled. Ipsen is a founding member of the first Clubhouse France, an association that supports people suffering from mental illness.
For several years, Ipsen has been a member of the Tulipe non-profit organization. Founded in 1982 in France, Tulipe pools medicines donated by pharmaceutical companies to meet urgent needs among populations affected by crisis, natural disasters and conflicts.
In Germany, Ipsen has made a donation to Dachverband Clowns in Medizin und Pflege Deutschland e.V., an association of clowns that work with children in hospitals and with the elderly in their homes.
In Italy, Ipsen has supported the work of Osservatorio Nazionale sulla Salute della Donna which conducts research and campaigns in the field of women’s health. The association has published a booklet for patients to answer their questions on breast cancer and infertility.
Ipsen supports the Candy Foundation, which aims to help low-income families, with children suffering from cerebral palsy, who do not have medical coverage. In 2014, more than 165 children were treated by the Candy Foundation in Mexico, Puebla and Morelos.
Every year since 2007, Ipsen Spain has organized the Brigadas Urológicas in Nicaragua, Guatemala and Honduras. Spanish urologists are provided to manage critical cases and train local urologists. Ipsen also contributes by supplying surgical equipment used during the procedures. More than 1300 surgeries have been performed since the launch of the project.
In Russia, Ipsen participates in a number of charitable initiatives, notably the international Children’s Day, where our Russian staff arrange events for disabled children. The teams invite well-known actors or clowns who entertain the children. Furthermore, some employees meet voluntarily to clean, repair and improve the pediatric area of a local hospital, in a gesture of collective social responsibility.
In Spain, in partnership with Sant Pau hospital in Barcelona, Ipsen is taking part in a tele-medicine project to improve the lives of patients. This program allows patients suffering from spasticity of the lower limbs to enhance their quality of life through a daily in-home exercise regime while maintaining contact with their doctor. The patient then goes to hospital only when an injection is required.
In the United Kingdom, Ipsen supports the NET Patient Foundation to produce the “Your guide to neuroendocrine tumors” video to explain the role of endocrine cells, the illness, its symptoms and treatment options.
In 2016, the European Neuroendocrine Tumour Society (ENETS) published a set of new and updated consensus guidelines on the management of patients with NETs. To help National Health Service NET specialist centers audit their practices against these new guidelines, a program was set up to offer Medical Education Goods and Services (MEGS) funding to perform this type of clinical review and enhance patient care by following evidence-based recommendations. Four MEGS awards were given in 2016
In the United States, Ipsen supports a range of patient support and advocacy organizations. Funding and employee support has been provided for activities such as Global NET Awareness Day, as well as supporting fundraising and disease awareness campaigns across the country. The Ipsen US Oncology Educational Grants Committee approved funding to support the Los Angeles Carcinoid Neuroendocrine Tumor Society’s (LACNETS) 2016 Monthly Patient Education Seminars and 2016 Annual Patient & Caregiver Educational Conference.
The Ipsen Fondation
The Ipsen Fondation was created in 1983 under the aegis of Fondation de France to highlight and share scientific knowledge that is emerging from key areas of research in life science and biomedicine. As science becomes more complex, we strive to build new connections between top experts, mentor junior scientists and engage citizens around the world. In particular, we passionately promote scientific progress irrespective of gender, race and country of origin.
In 2017, the Fondation Ipsen awarded annual prizes to reward outstanding research. The 16th Endocrine Regulation Prize was awarded to Bruce McEwen (Rockefeller University, United States) for his pioneering work on glucocorticoids, stress and neuronal degeneration.
The 22nd Longevity Prize was awarded to Andrzej Bartke (Southern Illinois University School of Medicine, United States) for his pioneering analysis of the molecular and hormonal mechanisms that can extend mammalian longevity in mice.
Engaging with external scientific discovery
In collaboration with the American Association for the Advancement of Science, we launched the Bridging Biomedical Worlds conference series in 2014 to boost cooperation among researchers, clinicians and industry scientists. The fourth edition took place in February 2018 in Singapore and explored ‘Genome Editing, the Next Frontier’ and the program covered revolutionary genome editing tools in various scientific fields, especially with respect to innovative therapies for cancer.
In a second event, developed in collaboration with the Karolinksa Institute, we examined how entrepreneurs can better serve patients through scientific innovation. This event in March 2018 was open to the public and engaged politicians, leading scientists and the business community.